A method of assessing the biological status of pathology in epithelial tissue
CA 2335773 A1 · Owner: Altmann, Gabriel G. · Inventors: Wade, Gregory R.; Altmann, Gabriel G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides a method for indicating a high or low risk of developing, pathology at specific sites along epithelial tissues according to a model of, carcinogenesis and measurements of activated enterocytes. The method determines the presence and the intensity of a "promoting environment," a region, of intestinal epithelial cells which are biochemically programmed as activated enterocytes to develop pathology sus as neoplasia or such as cancer in response, to certain signals. The model predicts that neoplasia can develop only in such an, environment when the promoting influence is sufficiently intense. In which case to, provide the ability to identify pathologic tissues If …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 13, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 13, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 13, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.